Identification of differential m6A RNA methylomes and ALKBH5 as a potential prevention target in the developmental neurotoxicity induced by multiple sevoflurane exposures.

Sevoflurane, as a commonly used inhaled anesthetic for pediatric patients, has been reported that multiple sevoflurane exposures are associated with a greater risk of developing neurocognitive disorder. N6-Methyladenosine (m6A), as the most common mRNA modification in eukaryotes, has emerged as a crucial regulator of brain function in processes involving synaptic plasticity, learning and memory, and neurodevelopment. Nevertheless, the relevance of m6A RNA methylation in the multiple sevoflurane exposure-induced developmental neurotoxicity remains mostly elusive. Herein, we evaluated the genome-wide m6A RNA modification and gene expression in hippocampus of mice that received with multiple sevoflurane exposures using m6A-sequencing (m6A-seq) and RNA-sequencing (RNA-seq). We discovered 19 genes with differences in the m6A methylated modification and differential expression in the hippocampus. Among these genes, we determined that a total of nine differential expressed genes may be closely associated with the occurrence of developmental neurotoxicity induced by multiple sevoflurane exposures. We further found that the alkB homolog 5 (ALKBH5), but not methyltransferase-like 3 (METTL3) and Wilms tumor 1-associated protein (WTAP), were increased in the hippocampus of mice that received with multiple sevoflurane exposures. And the IOX1, as an inhibitor of ALKBH5, significantly improved the learning and memory defects and reduced neuronal damage in the hippocampus of mice induced by multiple sevoflurane exposures. The current study revealed the role of m6A methylated modification and m6A-related regulators in sevoflurane-induced cognitive impairment, which might provide a novel insight into identifying biomarkers and therapeutic strategies for inhaled anesthetic-induced developmental neurotoxicity.

The mechanism of phonetic information in voice identity discrimination: a comparative study based on sighted and blind people.

Purpose: The purpose of this study is to examine whether phonetic information functions and how phonetic information affects voice identity processing in blind people. Method: To address the first inquiry, 25 normal sighted participants and 30 blind participants discriminated voice identity, when listening forward speech and backward speech from their own native language and another unfamiliar language. To address the second inquiry, combining articulatory suppression paradigm, 26 normal sighted participants and 26 blind participants discriminated voice identity, when listening forward speech from their own native language and another unfamiliar language. Results: In Experiment 1, not only in the voice identity discrimination task with forward speech, but also in the discrimination task with backward speech, both the sighted and blind groups showed the superiority of the native language. This finding supports the view that backward speech still retains some phonetic information, and indicates that phonetic information can affect voice identity processing in sighted and blind people. In addition, only the superiority of the native language of sighted people was regulated by the speech manner, which is related to articulatory rehearsal. In Experiment 2, only the superiority of the native language of sighted people was regulated by articulatory suppression. This indicates that phonetic information may act in different ways on voice identity processing in sighted and blind people. Conclusion: The heightened dependence on voice source information in blind people appears not to undermine the function of phonetic information, but it appears to change the functional mechanism of phonetic information. These findings suggest that the present phonetic familiarity model needs to be improved with respect to the mechanism of phonetic information.

Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells.

Glioblastoma (GBM) is characterized by exceptionally high intratumoral heterogeneity. However, the molecular mechanisms underlying the origin of different GBM cell populations remain unclear. Here, we found that the compositions of ribosomes of GBM cells in the tumour core and edge differ due to alternative RNA splicing. The acidic pH in the core switches before messenger RNA splicing of the ribosomal gene RPL22L1 towards the RPL22L1b isoform. This allows cells to survive acidosis, increases stemness and correlates with worse patient outcome. Mechanistically, RPL22L1b promotes RNA splicing by interacting with lncMALAT1 in the nucleus and inducing its degradation. Contrarily, in the tumour edge region, RPL22L1a interacts with ribosomes in the cytoplasm and upregulates the translation of multiple messenger RNAs including TP53. We found that the RPL22L1 isoform switch is regulated by SRSF4 and identified a compound that inhibits this process and decreases tumour growth. These findings demonstrate how distinct GBM cell populations arise during tumour growth. Targeting this mechanism may decrease GBM heterogeneity and facilitate therapy.